clinical trials for tirzepatide shows 47% greater weight loss vs. Wegovy Tirzepatide shows 47% greater weight
Description
Tutti i dati G
Canada, Brazil, and China are expected to follow later this year
Most see the $137B by 2035 for the oral GLP-1 market
Manufactured to high purity standards and supplied exclusively for scientific research use
#Wegovy #Healthcare #GLP1 #Savings
